Early treatment response assessment with [177Lu]PSMA whole-body-scintigraphy compared to interim PSMA-PET

Abstract Background Prostate-specific membrane antigen positron emission tomography (PSMA-PET) is an essential tool for patient selection before radioligand therapy (RLT). Interim-staging with PSMA-PET during RLT allows for therapy monitoring. However, its added value over post-treatment imaging is...

Full description

Bibliographic Details
Published in:Cancer Imaging
Main Authors: David Ventura, Philipp Rassek, Philipp Schindler, Burak Han Akkurt, Linus Bredensteiner, Martin Bögemann, Katrin Schlack, Robert Seifert, Michael Schäfers, Wolfgang Roll, Kambiz Rahbar
Format: Article
Language:English
Published: BMC 2024-09-01
Subjects:
[177Lu]PSMA
Radioligand therapy
WBS
PSMA-PET
mCRPC
Online Access:https://doi.org/10.1186/s40644-024-00773-w

Internet

https://doi.org/10.1186/s40644-024-00773-w

Similar Items